At this stage of the pandemic, when behavioural change is so key to vaccine take-up, the government ignores the views of the public at its peril.
L’expertise universitaire, l’exigence journalistique
Articles sur Vaccine hesitancy
Affichage de 101 à 120 de 203 articles
People who haven’t gotten vaccinated for COVID-19 often have complex reasons for their relunctance or may face other barriers. Lumping them all together undercuts the vaccination campaign.
With youth ages 12 and over eligible for COVID-19 vaccination — and as trials for younger children move ahead — parental hesitancy is emerging as the new challenge for COVID-19 vaccine programs.
With enough vaccine supplies coming online from October, the government has no excuse not to have all arrangements in place for an efficient vaccination program. Here’s what needs to change.
Should people be compelled to take the vaccine? Should you feel guilty for skipping the line? And what about parts of the world where vaccines aren’t readably available? Ethicists have it covered.
The rules around allocation, and the enforcement of those rules, can’t rest with each individual. Responsibility lies with those in charge of delivering vaccines.
Our attitudes and behaviours are shaped by what others in society do. So there’s a real danger that vaccine hesitancy, when reported widely in the media, could catch on to more people.
Canadians are increasingly turning to private messaging apps where COVID-19 misinformation and conspiracy theories spread in an unregulated manner.
In Australia, a preference for a particular brand of COVID vaccine is likely to change, depending on the latest health advice, and media reports.
Psychologists have identified three potential barriers to vaccination: capability, opportunity and motivation.
People who are afraid of needles are twice as likely to be vaccine hesitant, new research shows.
The federal government is due to launch a new advertising campaign for COVID-19 vaccines in July. This is a chance to offer something more engaging than what we’ve seen to date.
If we think about the success of the UK’s vaccine rollout to date, and factor in how social norms tend to diffuse, then there’s good reason to be optimistic.
Free doughnuts and lotteries may drive some people to get their COVID-19 vaccine. But for those who are afraid of needles, other interventions may be necessary.
History tells us the public will tolerate risk of harm from a vaccine if their fear of the disease exceeds their fear of the vaccine.
Age and education level are the main factors associated with vaccine hesitancy. While this affects Māori and Pacific communities, basic access to health care and information is more important.
Answers to key questions about rare blood clots linked to AstraZeneca’s COVID-19 vaccine, including risks, symptoms and whether people who have had one AstraZeneca shot should have a second.
As vaccine eligibility is expanded to adolescents and young adults, understanding who might be more likely to be vaccine hesitant, and why, can help inform public health strategies
From free beers to lottery tickets, many jurisdictions around the world have introduced vaccine incentives. Is it time for Australia to do the same?
Many over 50s seem to be asking this question. But there are a number of reasons it’s important to go ahead and get the AstraZeneca vaccine now.
Les contributeurs les plus fréquents
-
Assistant Professor of Political Science, Oklahoma State University
-
Associate professor, UNSW Sydney
-
Research Fellow, Vaccine Uptake Group, Murdoch Children's Research Institute
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
-
Associate Professor, School of Social Sciences, The University of Western Australia
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Professor, Susan Wakil School of Nursing and Midwifery, University of Sydney
-
Executive Director, African Population and Health Research Center
-
Assistant Professor of Health Policy and Managment, School of Public Health, Texas A&M University
-
Senior Lecturer, School of Communication, Journalism and Marketing, Massey University
-
Senior Scientist, Cochrane South Africa, South African Medical Research Council (SAMRC) and Honorary researcher, Division of Social & Behavioural Sciences, School of Public Health, UCT, South African Medical Research Council
-
Director, Center for Public Interest Communications, University of Florida
-
Associate Professor, The University of Western Australia
-
Senior Research Fellow, Oxford Uehiro Centre for Practical Ethics, University of Oxford
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
